| The Antidepressant Effects Of The NMDA Antagonist, CP-101,606, In Patients With MDD (NCT00163059) | Pfizer | 2004-05-01 |
| A Study of the Efficacy and Safety of Varenicline in Japanese Smokers Motivated to Quit Smoking (NCT00635401) | Pfizer | 2004-05-01 |
| A Phase 2 Study of the Safety and Efficacy of a Tofimilast in Adult Patients With Chronic Obstructive Pulmonary Disease (NCT00219622) | Pfizer | 2004-05-01 |
| A Drug Use Investigation of ENBREL for Post-marketing Surveillance (PMS) for RA and PsA (NCT00195403) | Pfizer | 2004-05-01 |
| Long Term Study With B2036-PEG (NCT00143416) | Pfizer | 2004-04-01 |
| Intravenous Edotecarin in Patients With Advanced Gastric Cancer That Has Progressed or Recurred After Chemotherapy (NCT00087503) | Pfizer | 2004-04-01 |
| Long-Term Open-Label Extension Trial for Subjects Completing the Phase 3 Trial of Fesoterodine (SP584) for the Treatment of Overactive Bladder Syndrome (NCT00220376) | Pfizer | 2004-04-01 |
| Rollover Protocol for Prior SU011248 Protocols (NCT00798889) | Pfizer | 2004-03-01 |
| Double-Blind, Randomized Study Of The Analgesic Efficacy And Safety Of Valdecoxib 20 Mg Daily And Valdecoxib 20 Mg Twice Daily Compared To Placebo For Management Of Acute Postsurgical Pain In Anterior Cruciate Ligament (ACL) Reconstruction (NCT00650039) | Pfizer | 2004-03-01 |
| A Multicentre, Double-Blind, Double-Dummy, Randomised Study of the Analgesic Efficacy and Safety of Valdecoxib Compared to Diclofenac Sodium in Patients Undergoing Knee Arthroscopy for Anterior Cruciate Ligament (ACL) Reconstruction (NCT00650598) | Pfizer | 2004-03-01 |
| Immunogenicity and Safety Study of a Rapid Immunization Schedule With FSME-IMMUN 0.5 mL in Healthy Adults Aged 16 - 65 Years (NCT00161954) | Pfizer | 2004-03-01 |
| Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine For The Treatment Of Uncomplicated, Symptomatic Falciparum Malaria In Southeast Asia (NCT00084240) | Pfizer | 2004-03-01 |
| A Study of SU11248 In Patients With Metastatic Breast Cancer Who Have Failed Selected Other Therapies. (NCT00078000) | Pfizer | 2004-03-01 |
| AG-013736 In Combination With Docetaxel Versus Docetaxel Alone For Patients With Metastatic Breast Cancer (NCT00076024) | Pfizer | 2004-02-01 |
| Post Marketing Surveillance Study on Linezolid (NCT01564758) | Pfizer | 2004-02-01 |
| Efficacy and Safety Study of Binodenoson in Assessing Cardiac Ischemia (NCT00944294) | Pfizer | 2004-02-01 |
| A Pivotal Study Of SU011248 In The Treatment Of Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma. (NCT00077974) | Pfizer | 2004-02-01 |
| MEK Inhibitor PD-325901 To Treat Advanced Breast Cancer, Colon Cancer, And Melanoma. (NCT00147550) | Pfizer | 2004-02-01 |
| Placebo Controlled Dose-Response Study Of PD-217,014 In The Treatment Of Postherpetic Neuralgia (NCT00159640) | Pfizer | 2004-02-01 |
| A Study To Investigate The Effect Of PD-217,014 On Abdominal Pain/Discomfort In Patients With IBS. (NCT00139672) | Pfizer | 2004-01-01 |
| Non Interventional Study For Patients Treated With Somavert® (NCT00858143) | Pfizer | 2004-01-01 |
| A Multicenter Trial to Investigate Fesoterodine Sustained Release in Overactive Bladder Syndrome (NCT00220363) | Pfizer | 2004-01-01 |
| A Study Of The Safety And Efficacy Of AG-013,958 In Subjects With Subfoveal Choroidal Neovascularization Associated With Age-Related Macular Degeneration (NCT00090532) | Pfizer | 2004-01-01 |
| Study To Examine Effect Of CP-866,087 On Consumption And Craving Of Alcohol In Alcohol Dependent Subjects. (NCT00147576) | Pfizer | 2003-12-01 |
| A Trial Of SU14813 In Patients With Advanced Solid Malignancies (NCT00982267) | Pfizer | 2003-12-01 |
| CP-751,871 Treatment For Patients With Multiple Myeloma (NCT01536145) | Pfizer | 2003-12-01 |
| Carotid B-Mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrpib/Atorvastatin to Atorvastatin Alone. (NCT00136981) | Pfizer | 2003-12-01 |
| Assessment Of Safety And Efficacy Of SU11248 In Patients With Metastatic Colorectal Cancer Who Have Failed Selected Previous Treatments. (NCT00077987) | Pfizer | 2003-12-01 |
| Study of [S,S]-Reboxetine in Patients With Postherpetic Neuralgia, Who Are Gabapentin Treatment Failures (NCT00143442) | Pfizer | 2003-12-01 |
| CPG 7909 Injection in Melanoma (NCT00070642) | Pfizer | 2003-12-01 |
| Safety And Efficacy Of Rescriptor In Patients For Human Immunodeficiency Virus (HIV) Patients (NCT00823966) | Pfizer | 2003-12-01 |
| Study of the GARFT Inhibitor AG2037 in Patients With Metastatic Colorectal Cancer Who Failed Treatment (NCT00078468) | Pfizer | 2003-12-01 |
| A Study To Assess The Safety And Efficacy Of SU11248 In Patients With Gastrointestinal Stromal Tumor(GIST) (NCT00075218) | Pfizer | 2003-12-01 |
| Irinotecan in Patients With Advanced Metastatic Breast Cancer Who Have Experienced Failure of an Anthracycline, a Taxane, and Capecitabine (NCT00072852) | Pfizer | 2003-11-01 |
| Carotid B-mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrapib/Atorvastatin to Atorvastatin. (NCT00134238) | Pfizer | 2003-11-01 |
| Zithromax EV in Community-Acquired Pneumonia (CAP) (NCT00137007) | Pfizer | 2003-11-01 |
| A Coronary IVUS Study to Compare Torcetrapib/Atorvastatin to Atorvastatin Alone in Subjects With Coronary Heart Disease (NCT00134173) | Pfizer | 2003-10-01 |
| Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Renal Cell Carcinoma (NCT00076011) | Pfizer | 2003-10-01 |
| Clinical Study Assessing a New Scale to Measure Onset of Action in Generalized Anxiety Disorder (NCT00715039) | Pfizer | 2003-10-01 |
| Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 To Treat Small-Volume Ovarian, Peritoneal, Fallopian Tube Cancer (NCT00074867) | Pfizer | 2003-10-01 |
| A 52-Week Placebo-Controlled Study Evaluating the Safety of Varenicline (NCT00143299) | Pfizer | 2003-10-01 |
| Compare Effectiveness of Eplerenone vs Atenolol in Reversing the Remodelling Resistance Arteries in Subjects With HT (NCT00147563) | Pfizer | 2003-10-01 |
| Trial to Investigate the Efficacy, Tolerability and Safety of Fesoterodine Sustained Release in Subjects With Overactive Bladder Syndrome (NCT00138723) | Pfizer | 2003-10-01 |
| Pharmacokinetics Of CP-690,550 In Patients With Impaired Renal Function (NCT01740362) | Pfizer | 2003-10-01 |
| Pegvisomant And Sandostatin LAR Combination Study (NCT00068029) | Pfizer | 2003-10-01 |
| Non-Comparative Study To Evaluate Changes In FMD After Quinapril Therapy In Hypertensive Women (NCT00147524) | Pfizer | 2003-10-01 |
| Trial of Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine for the Treatment of Uncomplicated Malaria in India (NCT00074841) | Pfizer | 2003-09-01 |
| A Study Of CP-690,550 In Stable Kidney Transplant Patients (NCT01710033) | Pfizer | 2003-09-01 |
| CP-481,715 Nickel Allergy Study. (NCT00141180) | Pfizer | 2003-09-01 |
| Effect Of A Treatment Optimization Program To Improve Satisfaction With Viagra (NCT00159848) | Pfizer | 2003-09-01 |
| AG-013736 (Axitinib) In Patients With Poor Prognosis Acute Myeloid Leukemia (AML) Or Myelodysplastic Syndrome (MDS) (NCT00071006) | Pfizer | 2003-09-01 |
| A Study to Evaluate the Efficacy and Safety of CP-101,606 in Subjects With an Acute Stroke (NCT00073476) | Pfizer | 2003-09-01 |
| Study of IV Edotecarin Vs Temozolomide or Carmustine (BCNU) or Lomustine (CCNU) in Patients With Glioblastoma Multiforme (NCT00068952) | Pfizer | 2003-08-01 |
| Study Evaluating CMC-544 In B-Cell Non-Hodgkin's Lymphoma (NCT00073749) | Pfizer | 2003-08-01 |
| Celecoxib Versus Diclofenac In The Treatment Of Osteoarthritis Of The Hip (NCT00174317) | Pfizer | 2003-08-01 |
| Long-Term Safety Of DVS-233 SR In Patients With Major Depressive Disorder (NCT01309542) | Pfizer | 2003-08-01 |
| Safety, Tolerance and Pharmacokinetics of Anidulafungin in Immunocompromised Children Ages 2-17 (NCT00056381) | Pfizer | 2003-07-01 |
| A Double-Blind, Double Dummy, Randomized Comparison Study Of The Efficacy And Safety Of Valdecoxib 10mg Once Daily And Naproxen 500mg Twice Daily In Treating The Signs And Symptoms Of Osteoarthritis Of The Knee Or Hip In Taiwan (NCT00648258) | Pfizer | 2003-07-01 |
| Study Evaluating Interferon And CCI-779 In Advanced Renal Cell Carcinoma (NCT00065468) | Pfizer | 2003-07-01 |
| A Double-blind, Double-dummy, Multicenter, Randomized Study of the Efficacy and Tolerability of Valdecoxib 40 mg Versus Rofecoxib 50 mg in Treating the Symptoms of Ankle Sprain (NCT00657449) | Pfizer | 2003-06-04 |
| A Dose-Ranging Study Of Valdecoxib 5 Mg, 10 Mg, And 20 Mg Once Daily Versus Placebo In Patients With Osteoarthritis Of The Knee (Japan) (NCT00650624) | Pfizer | 2003-06-01 |
| A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With Placebo and Zyban for Smoking Cessation (NCT00143364) | Pfizer | 2003-06-01 |
| Two Phase Extension Trial of SP668 to Investigate the Safety and Tolerability of Sustained Release Fesoterodine in Subjects With Overactive Bladder: a Double-Blind Phase Followed by an Open-Label Extension Phase (NCT00220389) | Pfizer | 2003-06-01 |
| Time To Efficacy and Onset Of Action Of Linezolid (NCT00147511) | Pfizer | 2003-06-01 |
| Study in Women With Metastatic Breast Cancer Whose Cancer Has Gotten Worse After Anthracycline and Taxane Therapy (NCT00067314) | Pfizer | 2003-06-01 |
| Follow-up Study on the Antibody Response to Hepatitis B, Acellular Pertussis Toxin and Inactivated Poliovirus Antigens 1 Month After the 4th Hexavac® Vaccination in Healthy Children, Who Participated in NeisVac-C Study 216 (NCT00161941) | Pfizer | 2003-06-01 |
| A Study to Investigate the Pharmacokinetics, Safety and Tolerability of Voriconazole in Children (NCT00174473) | Pfizer | 2003-06-01 |
| A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With Placebo and Zyban for Smoking Cessation (NCT00141206) | Pfizer | 2003-05-01 |
| Study Evaluating Prevenar in the Prevention of Invasive Pneumococcal Disease (IPD) in the Paediatric Population in Spain. (NCT00227188) | Pfizer | 2003-05-01 |
| CPG 7909 Injection in Non-Small Cell Lung Cancer (NCT00070629) | Pfizer | 2003-05-01 |
| A Multicenter, Randomized, Double-Blind, Double-Dummy Study Of Azithromycin SR Versus Amoxicillin For The Treatment Of Strep Throat In Children (NCT00643149) | Pfizer | 2003-05-01 |
| Study Evaluating Sumanirole for the Treatment of the Signs and Symptoms of Early Parkinson's Disease (NCT00058838) | Pfizer | 2003-04-01 |
| Prophylaxis In Venous Thromboembolism In Primary Care, A Pilot Study (NCT00655122) | Pfizer | 2003-04-01 |
| A Study of the Efficacy and Safety of Voriconazole for the Treatment of Fungal Infections (NCT00647907) | Pfizer | 2003-04-01 |
| A Study To Compare The Efficacy And Safety Of Pegvisomant To That Of Sandostatin Lar Depot In Patients With Acromegaly (NCT00068042) | Pfizer | 2003-04-01 |
| A Study of the Recovery Benefits After Treatment With Parecoxib/Valdecoxib in Patients Undergoing Abdominal Surgery (NCT00651300) | Pfizer | 2003-04-01 |
| A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Mild to Moderate Pneumonia in Adult Patients (NCT00643734) | Pfizer | 2003-04-01 |
| Treatment With SU11248 in Patients With Neuroendocrine Tumors (NCT00056693) | Pfizer | 2003-04-01 |
| A Study To Evaluate The Efficacy Of Eplerenone Compared With Losartan For The Treatment Of Patients With Mild To Moderate Hypertension (NCT00649311) | Pfizer | 2003-04-01 |
| A 52-Week Multicenter Study Evaluating the Safety and Efficacy of Varenicline for the Maintenance of Smoking Cessation (NCT00143286) | Pfizer | 2003-04-01 |
| Continuing Access to Axitinib (A406- AG- 013736 ) For Patients Previously Receiving AG 013736 In Clinical Trials (NCT00828919) | Pfizer | 2003-03-07 |
| Efficacy and Safety of Celecoxib as Add-on Therapy to Risperidone Versus Risperidone Alone in Patients With Schizophrenia (NCT00639483) | Pfizer | 2003-03-01 |
| The Safety and Efficacy of Anidulafungin Versus Comparator in Patients With Candidemia and Invasive Candidiasis (NCT00056368) | Pfizer | 2003-03-01 |
| A Long-Term, Open-Label Study to Evaluate the Safety of Sitaxsentan Sodium Treatment in Patients With Pulmonary Arterial Hypertension (NCT00811018) | Pfizer | 2003-03-01 |
| Long-Term Safety Study of Inhaled Insulin: An Up to Four-Year Extension of Therapy in Subjects With Type 1 or Type 2 Diabetes Mellitus (NCT00143247) | Pfizer | 2003-03-01 |
| Three Combinations Of Docetaxel And Irinotecan For Recurrent Or Metastatic Non Small Cell Lung Cancer (NCT00139711) | Pfizer | 2003-03-01 |
| A Study to Evaluate the Efficacy of Tolterodine Prolonged Release Compared With Propiverine for the Treatment of Korean Patients With Overactive Bladder as Assessed by Ambulatory Urodynamic Monitoring (NCT00646880) | Pfizer | 2003-03-01 |
| Pharmacokinetics And Dialysability Of CP-690,550 In Subjects With End-Stage Renal Disease (NCT01710020) | Pfizer | 2003-02-01 |
| A Comparison Of Valdecoxib 20 Mg Twice Daily and 40 Mg Daily and Placebo In The Treatment Of Sore Throat (NCT00647829) | Pfizer | 2003-02-01 |
| Efficacy and Safety of Valdecoxib and Naproxen in Treating the Signs and Symptoms of Rheumatoid Arthritis (RA) in a Severe Rheumatoid Arthritis Patients (NCT00650455) | Pfizer | 2003-02-01 |
| A Study to Determine if Antibiotics Prevent Infection in the Pancreas of Patients Where Part of the Pancreas Has Died (NCT00061438) | Pfizer | 2003-02-01 |
| Trial Of Irinotecan In Combination With Three Methods Of Administration Of Fluoropyrimidine. (NCT00101686) | Pfizer | 2003-02-01 |
| A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With Asthma (NCT00139659) | Pfizer | 2003-01-01 |
| A Phase 2, Randomized, Open-Label Study Of Single Agent CI-1033 In Patients With Advanced Non-Small Cell Lung Cancer (NCT00050830) | Pfizer | 2003-01-01 |
| Study of the Safety and Efficacy of SU-011,248 in Adult Patients With Advanced Kidney Cancer (NCT00054886) | Pfizer | 2003-01-01 |
| A Single, High-Dose Azithromycin Extended Release (60 mg/kg) Compared With 10 Days of High-Dose Amoxicillin Clavulanate in Children With Ear Infections at High Risk of Persistent/Recurrent Ear Infections (NCT00643292) | Pfizer | 2003-01-01 |
| A Study to Determine the Efficacy and Safety of Cabergoline for the Treatment of Patients With RLS (NCT00625547) | Pfizer | 2003-01-01 |
| A Study Comparing the Efficacy and Safety of Valdecoxib Plus Parecoxib Versus Valdecoxib Plus Placebo for the Treatment of Pain After Coronary Artery Bypass Surgery (NCT00636064) | Pfizer | 2003-01-01 |
| A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With COPD (NCT00138671) | Pfizer | 2003-01-01 |
| Linezolid for the Treatment of Infections Caused by Methicillin Resistant Staphylococcus Aureus in Japan (NCT00150332) | Pfizer | 2003-01-01 |